Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodeoxycholic Acid for Cholesterol Gallbladder Stones in China
ChiCTR2100053380Phase 4Recruiting
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Dec 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ursodeoxycholic acid in cholelithiasis (2 arms), sponsored by Shanghai Changzheng Hospital. Primary endpoint: Complete dissolution rate of gallbladder stones at 12 months. Started Dec 2021; status: recruiting.
02
Drugs
ursodeoxycholic acid
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on ChiCTR2100053380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053380.